Related references
Note: Only part of the references are listed.Innate immunity: the first line of defense against SARS-CoV-2
Michael S. Diamond et al.
NATURE IMMUNOLOGY (2022)
Neuropeptide Y as a risk factor for cardiorenal disease and cognitive dysfunction in chronic kidney disease: translational opportunities and challenges
Carmine Zoccali et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2022)
Colchicine use and the risk of CKD progression: a multicentre nested case-control study
Hyung Woo Kim et al.
RHEUMATOLOGY (2022)
Cellular Senescence in Cardiovascular Diseases: A Systematic Review
Can Hu et al.
AGING AND DISEASE (2022)
Genetic analysis of over half a million people characterises C-reactive protein loci
Saredo Said et al.
NATURE COMMUNICATIONS (2022)
A randomized controlled pilot trial of anakinra for hemodialysis inflammation
Laura M. Dember et al.
KIDNEY INTERNATIONAL (2022)
Interleukin-6 and Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes: New Insights From CANVAS
Akihiko Koshino et al.
DIABETES CARE (2022)
Nonsteroidal Mineralocorticoid Receptor Antagonism by Finerenone-Translational Aspects and Clinical Perspectives across Multiple Organ Systems
Peter Kolkhof et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
WNT-β-catenin signalling - a versatile player in kidney injury and repair
Stefan J. Schunk et al.
NATURE REVIEWS NEPHROLOGY (2021)
Microbiota-Mediated Immune Regulation in Atherosclerosis
Sahar Eshghjoo et al.
MOLECULES (2021)
Interleukin-6 Signaling and Anti-Interleukin-6 Therapeutics in Cardiovascular Disease
Paul M. Ridker et al.
CIRCULATION RESEARCH (2021)
Efficacy and safety of low-dose colchicine in patients with coronary disease: a systematic review and meta-analysis of randomized trials
Aernoud T. L. Fiolet et al.
EUROPEAN HEART JOURNAL (2021)
Genetically determined NLRP3 inflammasome activation associates with systemic inflammation and cardiovascular mortality
Stefan J. Schunk et al.
EUROPEAN HEART JOURNAL (2021)
Sodium and its manifold impact on our immune system
Katarzyna Jobin et al.
TRENDS IN IMMUNOLOGY (2021)
Chronic Inflammation in Chronic Kidney Disease Progression: Role of Nrf2
Peter Stenvinkel et al.
KIDNEY INTERNATIONAL REPORTS (2021)
Interleukin-1α Is a Central Regulator of Leukocyte-Endothelial Adhesion in Myocardial Infarction and in Chronic Kidney Disease
Stefan J. Schunk et al.
CIRCULATION (2021)
The Effect of Dietary Interventions on Chronic Inflammatory Diseases in Relation to the Microbiome: A Systematic Review
Carlijn A. Wagenaar et al.
NUTRIENTS (2021)
Interleukin 6 (rs1800795) and pentraxin 3 (rs2305619) polymorphisms-association with inflammation and all-cause mortality in end-stage-renal disease patients on dialysis
Susana Rocha et al.
SCIENTIFIC REPORTS (2021)
Chronic stress primes innate immune responses in mice and humans
Tessa J. Barrett et al.
CELL REPORTS (2021)
Interleukin 6 and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Chronic Coronary Syndrome
Gorav Batra et al.
JAMA CARDIOLOGY (2021)
Efficacy of statins on renal function in patients with chronic kidney disease: a systematic review and meta-analysis
Lin Zhao et al.
RENAL FAILURE (2021)
Genetically determined NLRP3 inflammasome activation associates with systemic inflammation and cardiovascular mortality
Stefan J. Schunk et al.
EUROPEAN HEART JOURNAL (2021)
Effects of Interleukin-1β Inhibition on Incident Anemia Exploratory Analyses From a Randomized Trial
Mounica Vallurupalli et al.
ANNALS OF INTERNAL MEDICINE (2020)
SGLT2 inhibition modulates NLRP3 inflammasome activity via ketones and insulin in diabetes with cardiovascular disease
So Ra Kim et al.
NATURE COMMUNICATIONS (2020)
Effects of Interleukin-1β Inhibition on Incident Hip and Knee Replacement Exploratory Analyses From a Randomized, Double-Blind, Placebo-Controlled Trial
Matthias Schieker et al.
ANNALS OF INTERNAL MEDICINE (2020)
Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019 Update From the GBD 2019 Study
Gregory A. Roth et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Inflammation and cardiovascular disease: From mechanisms to therapeutics
Abdulhamied Alfaddagh et al.
AMERICAN JOURNAL OF PREVENTIVE CARDIOLOGY (2020)
Dietary Inflammatory Potential and Risk of Cardiovascular Disease Among Men and Women in the US
Jun Li et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Potential role for interleukin-1 in the cardio-renal syndrome
Leo F. Buckley et al.
EUROPEAN JOURNAL OF HEART FAILURE (2019)
Cellular Senescence in the Kidney
Marie-Helena Docherty et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2019)
Activators and Inhibitors of NRF2: A Review of Their Potential for Clinical Development
Natalia Robledinos-Anton et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2019)
Novel Insights Into the NLRP3 Inflammasome in Atherosclerosis
Ying Jin et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2019)
A single number for advocacy and communication-worldwide more than 850 million individuals have kidney diseases
Kitty J. Jager et al.
KIDNEY INTERNATIONAL (2019)
ENaC-mediated sodium influx exacerbates NLRP3-dependent inflammation in cystic fibrosis
Thomas Scambler et al.
ELIFE (2019)
Exercise reduces inflammatory cell production and cardiovascular inflammation via instruction of hematopoietic progenitor cells
Vanessa Frodermann et al.
NATURE MEDICINE (2019)
Use of Measures of Inflammation and Kidney Function for Prediction of Atherosclerotic Vascular Disease Events and Death in Patients With CKD: Findings From the CRIC Study
Richard L. Amdur et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2019)
Neuropeptide Y predicts cardiovascular events in chronic kidney disease patients: a cohort study
Carmine Zoccali et al.
JOURNAL OF HYPERTENSION (2019)
Chronic inflammation in the etiology of disease across the life span
David Furman et al.
NATURE MEDICINE (2019)
Neuroimmune interactions and kidney disease
Sho Hasegawa et al.
KIDNEY RESEARCH AND CLINICAL PRACTICE (2019)
Overview of the IL-1 family in innate inflammation and acquired immunity
Charles A. Dinarello
IMMUNOLOGICAL REVIEWS (2018)
The NLRP3 inflammasome in acute myocardial infarction
Stefano Toldo et al.
NATURE REVIEWS CARDIOLOGY (2018)
Colchicine: an ancient drug with novel applications
B. Dasgeb et al.
BRITISH JOURNAL OF DERMATOLOGY (2018)
Western Diet Triggers NLRP3-Dependent Innate Immune Reprogramming
Anette Christ et al.
CELL (2018)
Enhanced Cardiomyocyte NLRP3 Inflammasome Signaling Promotes Atrial Fibrillation
Chunxia Yao et al.
CIRCULATION (2018)
Microbiome and Cardiovascular Disease in CKD
Anna Jovanovich et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2018)
Inhibition of Interleukin-1β by Canakinumab and Cardiovascular Outcomes in Patients With Chronic Kidney Disease
Paul M. Ridker et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Lowering LDL cholesterol reduces cardiovascular risk independently of presence of inflammation
Benjamin C. Storey et al.
KIDNEY INTERNATIONAL (2018)
Targeting the NLRP3 inflammasome in inflammatory diseases
Matthew S. J. Mangan et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Neuropeptide Y and chronic kidney disease progression: a cohort study
Carmine Zoccali et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2018)
MCC950, a specific small molecule inhibitor of NLRP3 inflammasome attenuates colonic inflammation in spontaneous colitis mice
Agampodi Promoda Perera et al.
SCIENTIFIC REPORTS (2018)
Molecular and Functional Neuroscience in Immunity
Valentin A. Pavlov et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 36 (2018)
Relationship of Interleukin-1β Blockade With Incident Gout and Serum Uric Acid Levels
Daniel H. Solomon et al.
ANNALS OF INTERNAL MEDICINE (2018)
A Review of Interleukin-1 in Heart Disease: Where Do We Stand Today?
Yishay Szekely et al.
CARDIOLOGY AND THERAPY (2018)
From haematopoietic stem cells to complex differentiation landscapes
Elisa Laurenti et al.
NATURE (2018)
Role of NLRP3 inflammasome in the pathogenesis of cardiovascular diseases
Dongling Liu et al.
BASIC RESEARCH IN CARDIOLOGY (2018)
The selective NLRP3-inflammasome inhibitor MCC950 reduces infarct size and preserves cardiac function in a pig model of myocardial infarction
Gerardus P. J. van Hout et al.
EUROPEAN HEART JOURNAL (2017)
Renal Denervation Reduces Monocyte Activation and Monocyte-Platelet Aggregate Formation An Anti-Inflammatory Effect Relevant for Cardiovascular Risk
Maria T. K. Zaldivia et al.
HYPERTENSION (2017)
Cellular senescence in renal ageing and disease
Ines Sturmlechner et al.
NATURE REVIEWS NEPHROLOGY (2017)
Symmetric dimethylarginine, high-density lipoproteins and cardiovascular disease
Stephen Zewinger et al.
EUROPEAN HEART JOURNAL (2017)
Mechanisms governing inflammasome activation, assembly and pyroptosis induction
Sannula Kesavardhana et al.
INTERNATIONAL IMMUNOLOGY (2017)
Inflammation and elevated levels of fibroblast growth factor 23 are independent risk factors for death in chronic kidney disease
Jair Munoz Mendoza et al.
KIDNEY INTERNATIONAL (2017)
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
Paul M. Ridker et al.
LANCET (2017)
Salt-responsive gut commensal modulates TH17 axis and disease
Nicola Wilck et al.
NATURE (2017)
Crystal nephropathies: mechanisms of crystal-induced kidney injury
Shrikant R. Mulay et al.
NATURE REVIEWS NEPHROLOGY (2017)
The systemic nature of CKD
Carmine Zoccali et al.
NATURE REVIEWS NEPHROLOGY (2017)
Meta-analysis of statins in chronic kidney disease: who benefits?
C. M. Messow et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2017)
CLICs-dependent chloride efflux is an essential and proximal upstream event for NLRP3 inflammasome activation
Tiantian Tang et al.
NATURE COMMUNICATIONS (2017)
Inhibition of Toll-Like Receptor Signaling as a Promising Therapy for Inflammatory Diseases: A Journey from Molecular to Nano Therapeutics
Wei Gao et al.
FRONTIERS IN PHYSIOLOGY (2017)
NF-kappa B signaling in inflammation
Ting Liu et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2017)
The Anti-Inflammatory Effects of Statins on Coronary Artery Disease: An Updated Review of the Literature
Evangelos Diamantis et al.
CURRENT CARDIOLOGY REVIEWS (2017)
Interleukin-1 Blockade in Recently Decompensated Systolic Heart Failure Results From REDHART (Recently Decompensated Heart Failure Anakinra Response Trial)
Benjamin W. Van Tassell et al.
CIRCULATION-HEART FAILURE (2017)
Effect of monoclonal antibodies to PCSK9 on high-sensitivity C-reactive protein levels: a meta-analysis of 16 randomized controlled treatment arms
Amirhossein Sahebkar et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2016)
A randomized phase II study of Xilonix, a targeted therapy against interleukin 1 alpha, for the prevention of superficial femoral artery restenosis after percutaneous revascularization
Hosam El Sayed et al.
JOURNAL OF VASCULAR SURGERY (2016)
NOD1/NOD2 signaling links ER stress with inflammation
A. Marijke Keestra-Gounder et al.
NATURE (2016)
Mechanism and Regulation of NLRP3 Inflammasome Activation
Yuan He et al.
TRENDS IN BIOCHEMICAL SCIENCES (2016)
Mechanism of TLR-4/NF-κB pathway in myocardial ischemia reperfusion injury of mouse
Hao Chen et al.
ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE (2016)
Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials
William G. Herrington et al.
LANCET DIABETES & ENDOCRINOLOGY (2016)
Untargeted plasma and tissue metabolomics in rats with chronic kidney disease given AST-120
Thomas J. Velenosi et al.
SCIENTIFIC REPORTS (2016)
Activation of NOD1 by DAP contributes to myocardial ischemia/reperfusion injury via multiple signaling pathways
Hui Yang et al.
APOPTOSIS (2015)
Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes
David P. Steensma et al.
BLOOD (2015)
NOD1, a new player in cardiac function and calcium handling
Carmen Delgado et al.
CARDIOVASCULAR RESEARCH (2015)
Myocardial Infarction Activates CCR2+ Hematopoietic Stem and Progenitor Cells
Partha Dutta et al.
CELL STEM CELL (2015)
TLR4 mutation and HSP60-induced cell death in adult mouse cardiac myocytes
J. P. Heiserman et al.
CELL STRESS & CHAPERONES (2015)
The Importance of NLRP3 Inflammasome in Heart Failure
Brittany Butts et al.
JOURNAL OF CARDIAC FAILURE (2015)
K+ Efflux Agonists Induce NLRP3 Inflammasome Activation Independently of Ca2+ Signaling
Michael A. Katsnelson et al.
JOURNAL OF IMMUNOLOGY (2015)
Cellular senescence in aging and age-related disease: from mechanisms to therapy
Bennett G. Childs et al.
NATURE MEDICINE (2015)
Association of a polymorphism of the interleukin 6 receptor gene with chronic kidney disease in Japanese individuals
Hideki Horibe et al.
NEPHROLOGY (2015)
Macrophages monitor tissue osmolarity and induce inflammatory response through NLRP3 and NLRC4 inflammasome activation
W. K. Eddie Ip et al.
NATURE COMMUNICATIONS (2015)
Continuous Reduction of Protein-Bound Uraemic Toxins with Improved Oxidative Stress by Using the Oral Charcoal Adsorbent AST-120 in Haemodialysis Patients
Suguru Yamamoto et al.
SCIENTIFIC REPORTS (2015)
Effect of Nutritional Status and Dietary Patterns on Human Serum C-Reactive Protein and Interleukin-6 Concentrations
Angelika Smidowicz et al.
ADVANCES IN NUTRITION (2015)
Association of IL-6 and a Functional Polymorphism in the IL-6 Gene with Cardiovascular Events in Patients with CKD
Belinda Spoto et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
Activation of an Innate Immune Receptor, Nod1, Accelerates Atherogenesis in Apoe-/- Mice
Shunsuke Kanno et al.
JOURNAL OF IMMUNOLOGY (2015)
Randomized Placebo-Controlled EPPIC Trials of AST-120 in CKD
Gerald Schulman et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
TXNIP mediates NLRP3 inflammasome activation in cardiac microvascular endothelial cells as a novel mechanism in myocardial ischemia/reperfusion injury
Yi Liu et al.
BASIC RESEARCH IN CARDIOLOGY (2014)
Single-Dose, Open-Label Study of the Differences in Pharmacokinetics of Colchicine in Subjects with Renal Impairment, Including End-Stage Renal Disease
Suman Wason et al.
CLINICAL DRUG INVESTIGATION (2014)
Formation of the inflammasome in acute myocarditis
Stefano Toldo et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2014)
The role of senescent cells in ageing
Jan M. van Deursen
NATURE (2014)
Novel targets of antifibrotic and anti-inflammatory treatment in CKD
Anne-Emilie Decleves et al.
NATURE REVIEWS NEPHROLOGY (2014)
Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes
Siddhartha Jaiswal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Mediterranean dietary pattern, inflammation and endothelial function: A systematic review and meta-analysis of intervention trials
L. Schwingshackl et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2014)
Role of Nrf2 in Oxidative Stress and Toxicity
Qiang Ma
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 53, 2013 (2013)
Increased risk of coronary heart disease among individuals reporting adverse impact of stress on their health: the Whitehall II prospective cohort study
Hermann Nabi et al.
EUROPEAN HEART JOURNAL (2013)
K+ Efflux Is the Common Trigger of NLRP3 Inflammasome Activation by Bacterial Toxins and Particulate Matter
Raul Munoz-Planillo et al.
IMMUNITY (2013)
Procalcitonin and the inflammatory response to salt in essential hypertension: a randomized cross-over clinical trial
Francesca Mallamaci et al.
JOURNAL OF HYPERTENSION (2013)
Inflammasome-Independent NLRP3 Augments TGF-β Signaling in Kidney Epithelium
Wenjie Wang et al.
JOURNAL OF IMMUNOLOGY (2013)
Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells
Markus Kleinewietfeld et al.
NATURE (2013)
Anti-Inflammatory Therapy in Chronic Disease: Challenges and Opportunities
Ira Tabas et al.
SCIENCE (2013)
Critical role of caspase-1 in vascular inflammation and development of atherosclerosis in Western diet-fed apolipoprotein E-deficient mice
Fumitake Usui et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Cell Volume Regulation Modulates NLRP3 Inflammasome Activation
Vincent Compan et al.
IMMUNITY (2012)
Nucleotide-Binding Oligomerization Domain-Like Receptors and Inflammasomes in the Pathogenesis of Non-Microbial Inflammation and Diseases
D. Randal Mason et al.
JOURNAL OF INNATE IMMUNITY (2012)
Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies
Nadeem Sarwar et al.
LANCET (2012)
High salt intake fails to enhance plasma adiponectin in normotensive salt-sensitive subjects
Fuqiang Liu et al.
NUTRITION (2012)
Critical role for calcium mobilization in activation of the NLRP3 inflammasome
Tomohiko Murakami et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Markers of inflammation predict the long-term risk of developing chronic kidney disease: a population-based cohort study
Anoop Shankar et al.
KIDNEY INTERNATIONAL (2011)
Oral activated charcoal adsorbent (AST-120) ameliorates extent and instability of atherosclerosis accelerated by kidney disease in apolipoprotein E-deficient mice
Suguru Yamamoto et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
Atherosclerosis in ApoE-deficient mice progresses independently of the NLRP3 inflammasome
P. Menu et al.
CELL DEATH & DISEASE (2011)
Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data
Frances Wensley et al.
BRITISH MEDICAL JOURNAL (2011)
Pattern Recognition Receptors and Inflammation
Osamu Takeuchi et al.
CELL (2010)
C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis
Stephen Kaptoge et al.
LANCET (2010)
Genetic Loci Associated With C-Reactive Protein Levels and Risk of Coronary Heart Disease
Paul Elliott et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Th17 cells at the crossroads of innate and adaptive immunity against infectious diseases at the mucosa
S. A. Khader et al.
MUCOSAL IMMUNOLOGY (2009)
Macrophages regulate salt-dependent volume and blood pressure by a vascular endothelial growth factor-C-dependent buffering mechanism
Agnes Machnik et al.
NATURE MEDICINE (2009)
Calcium Phosphate Crystals Induce Cell Death in Human Vascular Smooth Muscle Cells A Potential Mechanism in Atherosclerotic Plaque Destabilization
Alexandra E. Ewence et al.
CIRCULATION RESEARCH (2008)
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Paul M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Short-term changes in lipoprotein subclasses and C-reactive protein levels of hypertriglyceridemic adults on low-carbohydrate and low-fat diets
Colene K. Stoernell et al.
NUTRITION RESEARCH (2008)
Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor
Jean-Philippe Coppe et al.
PLOS BIOLOGY (2008)
Protein carbamylation links inflammation, smoking, uremia and atherogenesis
Zeneng Wang et al.
NATURE MEDICINE (2007)
Cellular senescence: when bad things happen to good cells
Judith Campisi et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
An oral adsorbent, AST-120, suppresses oxidative stress in uremic rats
Naoki Nakagawa et al.
AMERICAN JOURNAL OF NEPHROLOGY (2006)
Interleukin-1 gene cluster polymorphisms predict risk of ESRD
JB Wetmore et al.
KIDNEY INTERNATIONAL (2005)
Toll-like receptor 2 stimulation induces intimal hyperplasia and atherosclerotic lesion development
AH Schoneveld et al.
CARDIOVASCULAR RESEARCH (2005)
Increased toll-like receptor 4 in the myocardium of patients requiring left ventricular assist devices
EJ Birks et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2004)
Inflammation, endothelial dysfunction, and platelet activation in patients with chronic kidney disease: The Chronic Renal Impairment in Birmingham (CRIB) study
MJ Landray et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2004)
Evidence for altered interleukin (IL)-18 pathway in human heart failure
Z Mallat et al.
FASEB JOURNAL (2004)
Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E
KS Michelsen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Toll-like receptor-2 modulates ventricular remodeling after myocardial infarction
T Shishido et al.
CIRCULATION (2003)
A DNA damage checkpoint response in telomere-initiated senescence
FD di Fagagna et al.
NATURE (2003)
Expression of toll-like receptors in human atherosclerotic lesions - A possible pathway for plaque activation
K Edfeldt et al.
CIRCULATION (2002)
Share Paper
